A detailed history of Stephens Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Stephens Inc holds 158,881 shares of NVO stock, worth $16.7 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
158,881
Previous 121,296 30.99%
Holding current value
$16.7 Million
Previous $17.3 Million 9.26%
% of portfolio
0.28%
Previous 0.27%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$119.07 - $145.42 $4.48 Million - $5.47 Million
37,585 Added 30.99%
158,881 $18.9 Million
Q2 2024

Aug 06, 2024

BUY
$122.71 - $146.91 $2.94 Million - $3.52 Million
23,934 Added 24.58%
121,296 $17.3 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $2.87 Million - $3.82 Million
28,116 Added 40.6%
97,362 $12.5 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $372,626 - $447,635
4,245 Added 6.53%
69,246 $7.16 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $2.8 Million - $6.14 Million
30,782 Added 89.96%
65,001 $5.91 Million
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $707,057 - $782,622
-4,533 Reduced 11.7%
34,219 $5.54 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $835,594 - $1 Million
6,314 Added 19.46%
38,752 $6.17 Million
Q4 2022

Jan 25, 2023

SELL
$102.55 - $135.33 $65,426 - $86,340
-638 Reduced 1.93%
32,438 $4.39 Million
Q3 2022

Nov 02, 2022

BUY
$95.28 - $116.93 $137,393 - $168,613
1,442 Added 4.56%
33,076 $3.3 Million
Q2 2022

Aug 03, 2022

SELL
$103.24 - $121.81 $14,763 - $17,418
-143 Reduced 0.45%
31,634 $3.53 Million
Q1 2022

May 04, 2022

SELL
$93.1 - $112.54 $124,753 - $150,803
-1,340 Reduced 4.05%
31,777 $3.53 Million
Q4 2021

Mar 07, 2022

SELL
$95.88 - $117.08 $113,713 - $138,856
-1,186 Reduced 3.46%
33,117 $3.71 Million
Q3 2021

Oct 27, 2021

SELL
$84.42 - $106.62 $2.7 Million - $3.42 Million
-32,042 Reduced 48.3%
34,303 $3.29 Million
Q2 2021

Aug 12, 2021

BUY
$67.66 - $84.76 $1.58 Million - $1.98 Million
23,375 Added 54.4%
66,345 $5.56 Million
Q1 2021

May 14, 2021

BUY
$67.06 - $75.82 $610,111 - $689,810
9,098 Added 26.86%
42,970 $2.9 Million
Q4 2020

Feb 10, 2021

BUY
$63.89 - $73.8 $68,937 - $79,630
1,079 Added 3.29%
33,872 $2.37 Million
Q3 2020

Nov 13, 2020

BUY
$63.69 - $70.22 $15,986 - $17,625
251 Added 0.77%
32,793 $2.28 Million
Q2 2020

Aug 24, 2020

SELL
$58.54 - $67.94 $945,186 - $1.1 Million
-16,146 Reduced 33.16%
32,542 $2.13 Million
Q1 2020

May 14, 2020

BUY
$49.46 - $64.78 $54,554 - $71,452
1,103 Added 2.32%
48,688 $2.93 Million
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $119,564 - $139,707
2,398 Added 5.31%
47,585 $2.75 Million
Q3 2019

Oct 18, 2019

BUY
$47.54 - $53.43 $64,654 - $72,664
1,360 Added 3.1%
45,187 $2.34 Million
Q2 2019

Aug 01, 2019

BUY
$46.79 - $52.47 $169,894 - $190,518
3,631 Added 9.03%
43,827 $2.24 Million
Q1 2019

May 03, 2019

BUY
$46.36 - $52.63 $174,174 - $197,730
3,757 Added 10.31%
40,196 $2.1 Million
Q4 2018

Feb 11, 2019

BUY
$41.54 - $47.25 $106,217 - $120,818
2,557 Added 7.55%
36,439 $1.68 Million
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $1.58 Million - $1.74 Million
33,882 New
33,882 $1.6 Million
Q3 2017

Nov 08, 2017

SELL
$41.15 - $49.22 $1.84 Million - $2.2 Million
-44,643 Closed
0 $0
Q2 2017

Aug 10, 2017

BUY
N/A
44,643
44,643 $1.92 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Stephens Inc Portfolio

Follow Stephens Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.